1-8 of 8
Marjorie E Zettler, PhD MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Age-Based Disparities in Clinical Trials Supporting FDA Approval of Therapies for Hematologic Malignancies

Ajeet Gajra, MD MBBS, Marjorie E Zettler, PhD MPH, Eli G Phillips, Jr., PharmD, JD, Bruce Feinberg, DO
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-142064
Published: 2020
Journal Articles

Real-World Adverse Events Associated with Tisagenlecleucel in Acute Lymphoblastic Leukemia and Large B-Cell Lymphoma

Marjorie E Zettler, PhD MPH, Bruce Feinberg, DO, Alexandrina Balanean, Ajeet Gajra, MD MBBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 12.
https://doi.org/10.1182/blood-2020-142061
Published: 2020
Journal Articles

Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) Associated with PARP Inhibitors: A Real-World Analysis

Ajeet Gajra, MD MBBS, Marjorie E Zettler, PhD MPH, Andrew J Klink, PhD MPH, Bruce Feinberg, DO
Journal: Blood
Blood (2020) 136 (Supplement 1): 19.
https://doi.org/10.1182/blood-2020-142069
Published: 2020
Journal Articles

Real-World Analysis of Adverse Events Associated with CAR T-Cell Therapy Among Adults Age ≥65 Years

Marjorie E Zettler, PhD MPH, Bruce A Feinberg, DO, Eli G Phillips Jr., PharmD, JD, Andrew J Klink, PhD MPH, Sonam Mehta, Ajeet Gajra, MD FACP
Journal: Blood
Blood (2019) 134 (Supplement_1): 1951.
https://doi.org/10.1182/blood-2019-127372
Published: 2019
Journal Articles

Neurological Adverse Events Following CAR-T Cell Therapy: A Real-World Analysis of Adult Patients Treated with Axicabtagene Ciloleucel or Tisagenlecleucel

Ajeet Gajra, MD FACP, Marjorie E Zettler, PhD MPH, Eli G Phillips Jr., PharmD, JD, Andrew J Klink, PhD MPH, Jonathan K. Kish, PhD MPH, Sonam Mehta, Bruce Feinberg, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 1952.
https://doi.org/10.1182/blood-2019-129593
Published: 2019
Journal Articles

Adverse Events in Elderly Hodgkin Lymphoma Patients Treated with Pembrolizumab or Nivolumab in the Real World

Marjorie E Zettler, PhD MPH, Chadi Nabhan, MDMBA, FACP, Ajeet Gajra, MD FACP, Bruce Feinberg, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 3490.
https://doi.org/10.1182/blood-2019-129553
Published: 2019
Journal Articles

Patient-Reported Outcome Labeling for Malignant Hematology Drugs Approved in the United States: 2011-2017

Marjorie E Zettler, PhD MPH, Ethan Basch, MD MSc, Chadi Nabhan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2292.
https://doi.org/10.1182/blood-2018-99-116404
Published: 2018
Journal Articles

Fulfillment of Postmarketing Commitments for Novel Malignant Hematology Products Granted Accelerated Approval By the FDA between 2011-2016

Marjorie E Zettler, PhD MPH, Chadi Nabhan, MD MBA, FACP
Journal: Blood
Blood (2017) 130 (Supplement 1): 4712.
https://doi.org/10.1182/blood.V130.Suppl_1.4712.4712
Published: 2017